decrease of 6% compared to $105.3 million for the same period in 2009. Net loss under U.S. GAAP in the first half of 2010 was $(3.9) million or $(0.12) per basic and diluted share, compared to net income of $2.1 million or $0.07 per basic and diluted share in the first half of 2009.
AMRI Chairman, President and CEO Thomas E. D‘Ambra said, “Our second quarter results reflect the continued shift in demand from our customers for services in Asia and Europe, as evidenced by the significant contributions made by our international locations to our financial performance as compared to AMRI’s second quarter performance in 2009. Our ability to deliver high value services combined with our more cost effective facilities in Asia is driving demand throughout our organization. We are also excited about the opportunities now available to us through our recent acquisition of Hyaluron, provi- ding us with immediate entry into the rapidly grow- ing pre-filled syringe market. We are already reali- zing cross selling benefits between our organizations and we are optimistic about the growth and revenue synergy opportunities this acquisition offers.”
Total debt at June 30, 2010 was $13.2 million, down from $13.5 million at December 31, 2009. Cash, cash equivalents, and marketable securities, net of debt, were $47.2 million at June 30, 2010. Total common shares outstanding, net of treasury shares, were 31,791,214 at June 30, 2010. http://www.amriglobal.com
technologies and systems, reported financial results for the second quarter ended June 30, 2010. Finan-
ltair Nanotechnologies, Inc. (NASDAQ: ALTI), a provider of advanced lithium-ion battery
cial Highlights for second quarter 2010 compared to 2009:
• Revenue of $1.5 million compared to $(3,000); • Gross margin of $0.4 million compared to $(0.3); • Operating expenses of $5.5 million compared to $6.2 million;
• Net loss of $4.9 million compared to $6.4 million; • Net cash burn of $4.1 million compared to $(6.7).
In June, Altair Nanotechnologies had been granted a U.S. patent for the “Method of Producing Mixed Metal Oxides and Metal Oxide Compounds.” This patent protects the unique nanotechnology manuf- acturing process for battery anodes and cathodes in lithium-ion batteries utilizing a wider range of metal oxides. Furthermore, Altair has signed a long- term supply agreement with Proterra Inc. to supply advanced lithium-ion battery modules for incorpo- ration into Proterra‘s all-electric and hybrid-electric buses. The initial purchase order of $4.6 million is for delivery of modules through June 2011 with ongoing orders anticipated thereafter as Proterra continues to gain customer traction and completes its state-of-the- art manufacturing facility in Greenville, SC. This is a follow-on order to the two earlier orders announced in August 2009 and April 2010. http://www.altairnano.com
TSM) announced a long-term agreement that pro- vides TSMC with access to a broad range of ARM processors and enables the development of ARM physical IP across TSMC technology nodes. This ag- reement supports the companies’ mutual customers to achieve optimized Systems-On-Chip (SoC) based
RM and Taiwan Semiconductor Manufac- turing Company, Ltd. (TWSE: 2330, NYSE:
10-07/08 :: July/August 2010